Kratom (Mitragynine) Ingestion Requiring Naloxone Reversal

منو

" Kratom (Mitragynine) Ingestion Requiring Naloxone Reversal "
Overbeek, Daniel L.; Abraham, Jonathan; Munzer, Brendan W.

Document Type	:	AL
Record Number	:	928035
Doc. No	:	LA1s0870qm
Language of Document	:	English
Main Entry	:	Overbeek, Daniel L.; Abraham, Jonathan; Munzer, Brendan W.
Title & Author	:	Kratom (Mitragynine) Ingestion Requiring Naloxone Reversal [Article]\ Overbeek, Daniel L.; Abraham, Jonathan; Munzer, Brendan W.
Title of Periodical	:	Clinical Practice and Cases in Emergency Medicine
Volume/ Issue Number	:	3/1
Date	:	2019
Abstract	:	Kratom (mitragynine) is a naturally occurring opioid agonist whose use has been escalating. Its suppliers advertise it as a safe alternative for opioids and a safe treatment for opioid-withdrawal symptoms. There has been controversy in the past two years regarding the legal status and lack of regulation surrounding kratom. Currently, kratom is legal and unregulated, leaving users at risk from unpredictable potencies and effects. We present the first case of successful naloxone reversal of opioid toxidrome from recreationally used kratom. We advocate further research and regulation to ensure standardized dosing to protect patients.